ciclopirox has been researched along with Psoriasis in 3 studies
Psoriasis: A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Liang, S | 1 |
| Yang, Z | 1 |
| Hua, L | 1 |
| Chen, Y | 1 |
| Zhou, Y | 1 |
| Ou, Y | 1 |
| Chen, X | 1 |
| Yue, H | 1 |
| Yang, X | 1 |
| Wu, X | 1 |
| Hu, W | 1 |
| Sun, P | 1 |
| Cutrín Gómez, E | 1 |
| Anguiano Igea, S | 1 |
| Delgado-Charro, MB | 1 |
| Gómez Amoza, JL | 1 |
| Otero Espinar, FJ | 1 |
| Santagostino, L | 1 |
| Giorgetti, P | 1 |
| Di Cintio, R | 1 |
| Albanese, G | 1 |
3 other studies available for ciclopirox and Psoriasis
| Article | Year |
|---|---|
Ciclopirox inhibits NLRP3 inflammasome activation via protecting mitochondria and ameliorates imiquimod-induced psoriatic inflammation in mice.
Topics: Animals; Ciclopirox; Imiquimod; Inflammasomes; Inflammation; Interleukin-1beta; Lipopolysaccharides; | 2022 |
Microstructural alterations in the onychomycotic and psoriatic nail: Relevance in drug delivery.
Topics: Administration, Topical; Adult; Antifungal Agents; Ciclopirox; Clobetasol; Foot Dermatoses; Healthy | 2018 |
[Evaluation of the topical antimycotic treatment in psoriatic onychopathy with severe perionychia].
Topics: Administration, Topical; Antifungal Agents; Candidiasis, Cutaneous; Ciclopirox; Drug Evaluation; Fem | 1988 |